Board of Directors
Corporate Management
R&D Management
The Market
Our Beginnings
TauRx Group Fact Sheet
|
Board of Directors
| Prof. Claude Wischik, MD PhD. Executive Chairman and Co-founder |
|
|
| Prof. Wischik is board certified in psychiatry and Professor of Old Age Psychiatry at the University of Aberdeen, Scotland. A pioneer in tau research, Prof. Wischik's work on Tau pathology began in 1985 in the laboratory of Sir Martin Roth, who was the first to correlate tangles with Alzheimer's dementia, and later with Sir Aaron Klug (Nobel Laureate) at Cambridge University. Prof. Wischik subsequently discovered the Tau protein compositional structure of the Alzheimer tangles and established that it was possible to dissolve tangles with pharmaceutically viable compounds that act as Tau Aggregation Inhibitors. He also demonstrated a direct link between clinical dementia and Tau aggregation at the biochemical level, irrespective of ß-amyloid load in human brain. As TauRx chairman, Prof. Wischik has led the company to its present stage, has developed its portfolio of projects to the phase 2 clinical level and has worked with his Singaporean colleagues to raise a total of US$85m to date. |
| Mr Tay Siew Choon. Deputy Chairman |
|
| Mr Tay was the COO of Singapore Technologies Pte Ltd before he retired in 2004. Singapore Technologies was a multi-billion technology and industrial corporation and Mr Tay has many years of experience in managing diverse technology businesses. In addition to his position on the TauRx board, he is also a board member at WisTa Laboratories Ltd (a TauRx group company), Pan United Corporation Ltd and Straco Corporation Ltd. He holds a degree in electrical engineering and an MSc in systems engineering. |
| Dr. Seng Shay Way, MD. Managing Director |
|
| Dr Seng is a practising obstetrician, gynaecologist and reproductive specialist in Gleneagles Hospital. Dr Seng received his medical degree from the Royal College of Surgeons in Ireland and he is the first Singaporean to obtain the Masters of reproductive medicine from the University of New South Wales (Australia). He is currently a member of the Royal College of Obstetricians and Gynaecologists, London and a fellow of the Academy of Medicine, Singapore. He is the Medical director of Fertility Solutions Pte Ltd and is also a board member of Age D'Or Healthcare Pte Ltd.
|
| Prof. Stephen Logan, Director and Chairman of the Scientific Advisory Committee |
|
| Prof. Stephen Logan has been the Senior Vice-Principal of the University of Aberdeen since August 2004.
Professor Logan has held posts as Medical Research Council Fellow, Senior Lecturer and Professor of Neuroscience at the University of Birmingham. In 1994 he was appointed to be the first Professor of Neuroscience at the University of Aberdeen, subsequently Dean of the Medical School and Vice-Principal.
He is currently a member of the Chief Scientist's Advisory Committee (Health Department) and also is a member of the Steering Group of the Translational Medicine Research Collaboration which comprises the four Scottish Medical Schools and the NHS in Scotland with Scottish Enterprise and Wyeth Pharmaceuticals. He is also a Board Member of ACSEF, which was formally known as Scottish Enterprise Grampian, and a board member of WisTa Laboratories Ltd. (a TauRX group company) and PoreDeen Pte Ltd.
Professor Logan has previously been a member of the Scottish Higher Education Funding Council, SFC Research and Knowledge Transfer Committee and was also Deputy Convenor of Universities Scotland Health Committee. He has served as Chairman of Grampian University Hospitals NHS Trust and as a member of NHS Grampian.
Professor Logan is a neurophysiologist whose research interests are in the way the brain controls blood pressure, memory and appetite. He has published more than 100 scientific articles and has served on Research Council, Wellcome Trust and Health Department Advisory Panels.
He has key interests in strategic issues around creating and maintaining a world-class research base and the requirements for exploitation of intellectual property for wealth creation.
|
| Dr. Sushilan Vasoo, Director |
|
| Dr. Vasoo graduated from the University of Hong Kong with a PhD and Masters in Social Work and holds a Diploma in Social Studies with distinction from the University of Singapore. He was awarded the Jean Robertson Book prize at University of Hong Kong. Dr. Vasoo is currently also a board member of WisTa Laboratories Ltd. (a TauRx group company) and PoreDeen Pte Ltd, and an Associate Professorial Fellow in the Department of Social Work, National University of Singapore, an independent director of AEI Corporation, and Chairman of Seacare Education Pte Ltd. He was a Member of Parliament in the Government of Singapore from 1984 to 2001 and he also served as Chairman of the Government Parliamentary Committee for Community Development. He was appointed Justice of Peace, Singapore, in 2005. |
| Mr. George Chia, Director |
|
| Mr Chia has been running his own paper business for 42 years. He is also a board member of WisTa Laboratories Ltd. (a TauRx Group company) and PoreDeen Pte. Ltd, and is the Chairman of Premier Disposable Products Ltd (Hong Kong) and Guangdong Josco Disposable Product Ltd (China). Prior to his present appointment, Mr Chia was Managing Director of Kookaburra Paper Products Pte. Ltd and Premier Paper Doyleys Pte. Ltd |
| Mr Chung Meng Goh (Board, Alternate to Mr Tay Siew Choon) |
|
| Mr Goh graduated from the National University of Singapore with a Bachelor of Business Administration (BBA). He is also currently a Director of AVI-TECH Electronics Ltd and ACE Investment Management Pte Ltd. Prior to his present appointment, Mr. Goh had held senior positions in Deloitte & Touche Management Consultants, Carr Indosuez Asia (Merchant Banking unit of Credit Agricole and formerly known as Credit Agricole Indosuez) and Suez Asia Holdings (an Asian private equity fund). Mr. Goh had served as a Panel Member (2001 to 2008) of a Singapore government innovation and research fund, The Enterprise Challenge Unit (TEC), PS 21 Office, Public Service Division, Prime Minister's Office. |
| Dr. Loh Yin Sze (Board, Alternate to Dr Seng Shay Way) |
|
| Dr. Loh is a medical doctor who graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery. She did her clinical rotations in Singapore, and was also trained in molecular biology basic research. Dr. Loh was awarded the NUS-NUH Annual Meeting "Young Doctor Award" in 2004 for her research work in the field of discovery of novel therapeutics for use in prostate cancer. Dr. Loh has also worked as a Financial Research Analyst covering the healthcare, biomedical and pharmaceutical sectors when she was employed at Phillip Securities Pte. Ltd. |
| Professor Franz Theuring. (Board, Observer) |
|
| Prof Theuring graduated from the Universities of Brauschweig and Gottingen with a concentration in electronics and biology. He subsequently earned a PhD in the mechanisms of meiotic nondisjuntion from Gottingen, and worked as a post-doctoral research fellow at the Max Planck Institute for Biophysical Chemistry. Professor Theuring established transgenic technologies at the Planck Institute, and later at the Institute of Cellular and Molecular Biology of Schering AG. Professor Theuring received his Habilitation from the Free University of Berlin in Molecular Biology and Biochemistry in 1996, and after 8 years at Schering AG, was appointed in 1996 to a Professorship in Molecular Pharmacology at the Charite University Medicine Berlin. |
| Mr Frederick Stevenson-Robb. (Board, Alternate to Prof. Steve Logan) |
|
| Mr Stevenson graduated from the University of Aberdeen with a Master (Hons) in Psychology. He also holds a Post-Graduate Diploma in Personnel and Business Administration from the Robert Gordon University. He is also a board member of WisTa Laboratories and is the Director of Research and Innovation at the UA where he is responsible for Research Funding, Commercialisation and University Intellectual Property. Mr Stevenson-Robb is also a Director of Aberdeen University Research and Industrial Services, theUniversity holding company for much of its commercial investments, he is also a Director of Aberdeen Environmental Research Trust and New Era Exploration. Mr Stevenson-Robb was also co-founder of AUVATION Ltd, a drug discovery and development company. |
|